Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers
According to Sharath Chandra Guntuku, Research Associate Professor in Computer and Information Science (CIS) at Penn Engineering and the study's senior author, Some of the side effects we found, like nausea, are well known, and that shows that the method is picking up a real signal. The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them, Guntuku added
FIGURE 2 3.1 Brain insulin resistance Insulin resistance in the brain perpetuates neuroinflammation, tau hyperphosphorylation, and amyloid pathology in AD and is therefore a driver of neurodegenerative disease (Hlscher, 2019)
The current product solution in the pipeline is to develop orally effective GLP-1 receptor agonists using different carrier technologies
Clinical pharmacology studies showed that food does not significantly affect orforglipron's absorption